Cross-Sector entity
Of the tracked stories, 1 of 2 also mention C-MET, the most common co-covered peer. medical-devices accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Each carries 2 original sources on average. We currently track 2 Cross-Sector stories that mention AI-based breast cancer detection device, all published on March 11, 2026.
2 verified stories tracked
Last mentioned: Mar 11, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 1 of 2 also mention C-MET, the most common co-covered peer. medical-devices accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Each carries 2 original sources on average. We currently track 2 Cross-Sector stories that mention AI-based breast cancer detection device, all published on March 11, 2026.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering AI-based breast cancer detection device. Shared-story counts are live from our verified record — not editorial picks.
Lord's Mark Industries and the Centre for Materials for Electronics Technology (C-MET) have announced a historic collaboration to develop the world's first AI-driven breast cancer detection device. This partnership merges advanced materials science with machine learning to provide a non-invasive, early-stage screening solution.
Lords Mark Industries has entered a strategic partnership with the Center for Materials for Electronics Technology (C-MET) to develop a pioneering AI-based breast cancer detection device. This collaboration aims to leverage advanced materials and artificial intelligence to create a non-invasive, highly accurate screening tool for early-stage diagnosis.
Source: aninews.in · news.webindia123.com
